Nurix Therapeutics, Inc.: Form 10-Q for the period ended Aug 31, 2020
Filed with the SEC on Oct 14, 2020 and accepted by EDGAR at Oct 14, 2020, 16:02 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-08-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2020-06-01 to 2020-08-31 | $18.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2019-12-01 to 2020-08-31 | $46.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2020-06-01 to 2020-08-31 | −$19.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2019-12-01 to 2020-08-31 | −$45.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 9 months2019-12-01 to 2020-08-31 | −$20.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-06-01 to 2020-08-31 | −$18.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months2019-12-01 to 2020-08-31 | −$23.3m | us-gaap:NetIncomeLoss |
| Operating cash flow | 9 months2019-12-01 to 2020-08-31 | $20.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2019-12-01 to 2020-08-31 | $3.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2020-08-31 | $265.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-08-31 | $364.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-08-31 | $411.9m | us-gaap:Assets |
| Current liabilities | At period end2020-08-31 | $41.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-08-31 | $104.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-08-31 | $307.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-20-046400. Last ingested by Listed: Nov 5, 2026, 13:59 ET. Listed shows no prices and gives no investment advice.